These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. [Behavior of pancreatic beta-cells in type I and II diabetes: clinical implications?]. Waeber G Rev Med Suisse Romande; 1995 Sep; 115(9):627-34. PubMed ID: 7481346 [No Abstract] [Full Text] [Related]
47. Structural instability of mutant beta-cell glucokinase: implications for the molecular pathogenesis of maturity-onset diabetes of the young (type-2). Kesavan P; Wang L; Davis E; Cuesta A; Sweet I; Niswender K; Magnuson MA; Matschinsky FM Biochem J; 1997 Feb; 322 ( Pt 1)(Pt 1):57-63. PubMed ID: 9078243 [TBL] [Abstract][Full Text] [Related]
48. [Fundamental bases of search of medicines for therapy of a diabetes mellitus type 2]. Spasov AA; Petrov VI; Chepliaeva NI; Lenskaia KV Vestn Ross Akad Med Nauk; 2013; (2):43-9. PubMed ID: 23819328 [TBL] [Abstract][Full Text] [Related]
49. [Genetic causes of type 2 diabetes]. Malm D Tidsskr Nor Laegeforen; 1998 Mar; 118(7):1058-61. PubMed ID: 9531830 [TBL] [Abstract][Full Text] [Related]
50. [Early changes in the function of pancreatic beta cells and insulin pulsatility as predictors of type 2 diabetes]. Pørksen N Diabetes Metab; 1999 Dec; 25 Suppl 7():14-6. PubMed ID: 10746005 [TBL] [Abstract][Full Text] [Related]
51. [Action of metformin in insulin resistance]. Isnard F; Triadou N; Lavieuville M; Noël M Journ Annu Diabetol Hotel Dieu; 1985; ():307-17. PubMed ID: 2577974 [No Abstract] [Full Text] [Related]
52. Type II diabetes mellitus. Edelman SV Adv Intern Med; 1998; 43():449-500. PubMed ID: 9506190 [TBL] [Abstract][Full Text] [Related]
54. Maturity onset diabetes of the young (MODY). Fajans SS; Bell GI; Bowden DW; Halter JB; Polonsky KS Diabet Med; 1996 Sep; 13(9 Suppl 6):S90-5. PubMed ID: 8894490 [TBL] [Abstract][Full Text] [Related]
55. Insulin resistance and insulin deficiency in the pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: errors of metabolism or of methods? Groop LC; Widén E; Ferrannini E Diabetologia; 1993 Dec; 36(12):1326-31. PubMed ID: 8307264 [No Abstract] [Full Text] [Related]
56. Is GLUT2 required for glucose sensing? Schuit FC Diabetologia; 1997 Jan; 40(1):104-11. PubMed ID: 9028726 [No Abstract] [Full Text] [Related]
57. [Knockout mouse models for type 2 diabetes. Mice with impaired insulin secretion]. Terauchi Y; Kadowaki T Nihon Rinsho; 2002 Aug; 60 Suppl 8():58-63. PubMed ID: 12355812 [No Abstract] [Full Text] [Related]
58. [Insulin signaling and pathophysiology of type 2 diabetes mellitus]. Ogawa W; Kasuga M Nihon Rinsho; 2006 Jul; 64(7):1381-9. PubMed ID: 16838661 [TBL] [Abstract][Full Text] [Related]
59. Molecular insights into insulin action and secretion. Rhodes CJ; White MF Eur J Clin Invest; 2002 Jun; 32 Suppl 3():3-13. PubMed ID: 12028370 [TBL] [Abstract][Full Text] [Related]